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 Different studies assessed the role of inflammation in malignancy of different organs. 
Prostatitis has been suggested as a cause of cancer and BPH. Till now, more than 100 types of 
human Papilloma virus (HPV) are recognized including low and high-risk groups for 
carcinogenesis. Among them HPV-16 and HPV-18 have shown further association with cancer. 
Regarding the presence of E6 and E7 in HPV and ability for modification of basal epithelial cells, 
related role in prostate cancer (as well as cervical and genital malignancies) is hypothesized. The aim 
of this study was to determine the association of HPV-16 and HPV-18 with prostate cancer and 
malignancy degree. 
 A total of 75 consecutive paraffin-embedded blocks including 50 samples with primary 
prostate cancer and 25 samples with benign prostate hyperplasia (BPH) as control were studied. 
Amplisense kit was used for replication at real-time polymerase chain reaction (PCR) to determine 
genotypes of HPV-16 and HPV-18. DNA purity was assessed by Nano Drop. 
 The results of real-time PCR demonstrated that none of the samples of BPH and prostate 
cancer had amplification of HPV DNA. 
 The results revealed that HPV-16 and HPV-18 are not causes of prostate cancer. 
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Table 1. Temperature, time and number of cycles  in real-time PCR steps 
Step Temperature, °C Time Fluorescence detection Repeats 
 95 15 min - 1 
2 
95 20 s - 
45 
60 1 min FAM, JOE/HEX, ROX 
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Figure1. Real-Time PCR grahs 
 
Table 2. Relative frequency of the case group (based on the age group and  Gleason grouping) and control group based on the age group
Age Group (year) 
Case group based on Gleason Grouping   
1 2 3 4 5 BPH group Total 
40-49  1 (2%)  1 (2%)  2 (8%) 4 (5.3%) 
50-59 8 (%16) 5 (%10) 1(%2) 3 (%6) 2 (%4) 7 (%28) 26 (%54.7) 
60-69 6 (%12) 3 (%6) 1(%2) 3 (%6) 4 (%8) 8 (%32) 25 (%33.7) 
70-79 3 (%6) 2 (%4) 1(%2)  1(%2) 5 (%20) 12 (%16) 
80-89 1 (%2) 1(%2) 2 (%4) 1 (%2)  3 (%12) 8 (%10.7) 
Total 18 (%36) 12 (%24) 5 (%10) 8 (%16) 7 (%14) 25 (%100) 75 (%100) 
 
Table 3.The frequency distribution of PIN in the case group (based on Gleason grouping) and control group 
PIN* 
Pca Gleason grouping 
BPH 
1 2 3 4 5 
Low grade  3 (%6) 1 (%2) 2 (%4) 1 (%2) 5 (%20) 
High grade 1 (%2) 4 (%8) 7 (%14) 1 (%2) 5 (%10) 3 (%12) 
*Prostatic intraepithelial Neoplasia 
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Table 4. Frequency distribution of the case group (based on Gleason grouping) and control group according to the sampling method 
Sampling method PCa Gleason grouping  BPH 
 1 2 3 4 5  total  
TURP* 11 (%22) 7 (%14) 2 (%4) 3 (%6) 5 (%10) 28 (%56) 19 (%76) 
Core Needle Biopsy 7 (%14) 5 (%10) 3 (%6) 5 (%10) 2 (%4) 22 (%44) 6 (%24) 
Total 18 (%36) 12 (%24) 5 (%10) 8 (%16) 7 (%14) 50 (%100) 25(%100) 
*Trans-urethral resection of Prostate 
 
Discussion 
Non – Detection of HPV DNA in Prostatic cancer… Jafari, et al 
82 
References 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Journal of Kerman University of Medical Sciences 2017, Vol. 25, Issue 1 
83 
 
 
 
 
